Alignment Healthcare Operating Margin 2020-2025 | ALHC
Current and historical operating margin for Alignment Healthcare (ALHC) over the last 10 years. The current operating profit margin for Alignment Healthcare as of June 30, 2025 is -1.53%.
| Alignment Healthcare Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $3.34B | $-0.03B | -0.75% |
| 2025-03-31 | $3.00B | $-0.07B | -2.20% |
| 2024-12-31 | $2.70B | $-0.10B | -3.77% |
| 2024-09-30 | $2.47B | $-0.12B | -4.90% |
| 2024-06-30 | $2.23B | $-0.13B | -5.87% |
| 2024-03-31 | $2.01B | $-0.14B | -6.81% |
| 2023-12-31 | $1.82B | $-0.13B | -7.02% |
| 2023-09-30 | $1.72B | $-0.14B | -8.02% |
| 2023-06-30 | $1.62B | $-0.14B | -8.69% |
| 2023-03-31 | $1.53B | $-0.12B | -8.12% |
| 2022-12-31 | $1.43B | $-0.13B | -8.93% |
| 2022-09-30 | $1.37B | $-0.12B | -8.69% |
| 2022-06-30 | $1.30B | $-0.13B | -9.75% |
| 2022-03-31 | $1.25B | $-0.16B | -12.84% |
| 2021-12-31 | $1.17B | $-0.18B | -15.17% |
| 2021-09-30 | $1.11B | $-0.16B | -14.58% |
| 2021-06-30 | $1.07B | $-0.11B | -9.94% |
| 2021-03-31 | $1.00B | $-0.05B | -5.29% |
| 2020-12-31 | $0.96B | $-0.01B | -0.52% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.715B | $2.704B |
| Alignment Healthcare Inc. is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. Alignment Healthcare Inc. is based in ORANGE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.752B | 25.92 |
| CVS Health (CVS) | United States | $80.564B | 10.02 |
| Elevance Health (ELV) | United States | $62.217B | 8.37 |
| Cencora (COR) | United States | $55.003B | 18.32 |
| DiDi Global (DIDIY) | China | $25.321B | 26.90 |
| Labcorp Holdings (LH) | United States | $21.677B | 17.23 |
| Natera (NTRA) | United States | $18.861B | 0.00 |
| BioMerieux (BMXMF) | France | $17.067B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.801B | 0.00 |
| CochLear (CHEOY) | Australia | $13.308B | 0.00 |
| Solventum (SOLV) | United States | $12.556B | 13.29 |
| ICON (ICLR) | Ireland | $12.551B | 12.08 |
| Medpace Holdings (MEDP) | United States | $12.090B | 32.00 |
| Viatris (VTRS) | United States | $10.270B | 3.53 |
| Revvity (RVTY) | United States | $9.971B | 17.57 |
| Sonic Healthcare (SKHHY) | Australia | $9.035B | 0.00 |
| HealthEquity (HQY) | United States | $7.865B | 34.45 |
| Avantor (AVTR) | United States | $7.622B | 11.18 |
| Charles River Laboratories (CRL) | United States | $7.384B | 14.04 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.365B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.992B | 33.60 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.56 |
| BrightSpring Health Services (BTSG) | United States | $3.632B | 27.70 |
| Sotera Health (SHC) | United States | $3.139B | 17.84 |
| GeneDx Holdings (WGS) | United States | $3.020B | 69.64 |
| Surgery Partners (SGRY) | United States | $2.872B | 36.15 |
| Concentras Parent (CON) | United States | $2.556B | 14.77 |
| Organon (OGN) | United States | $2.267B | 2.47 |
| Progyny (PGNY) | United States | $2.014B | 44.32 |
| Premier (PINC) | United States | $1.821B | 13.82 |
| PACS (PACS) | United States | $1.684B | 0.00 |
| Ardent Health (ARDT) | United States | $1.616B | 6.24 |
| GoodRx Holdings (GDRX) | United States | $1.550B | 25.53 |
| Pediatrix Medical (MD) | United States | $1.258B | 8.40 |
| Teladoc Health (TDOC) | United States | $1.235B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.208B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.831B | 285.00 |
| CareDx (CDNA) | United States | $0.729B | 12.84 |
| AMN Healthcare Services Inc (AMN) | United States | $0.659B | 6.17 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| Embecta (EMBC) | United States | $0.577B | 3.89 |
| Nutex Health (NUTX) | United States | $0.520B | 7.87 |
| Omada Health (OMDA) | $0.501B | 0.00 | |
| So-Young (SY) | China | $0.500B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.458B | 10.32 |
| InnovAge Holding (INNV) | United States | $0.456B | 0.00 |
| SBC Medicals (SBC) | United States | $0.453B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.418B | 0.00 |
| Agilon Health (AGL) | United States | $0.369B | 0.00 |
| Oncology Institute (TOI) | United States | $0.363B | 0.00 |
| Enhabit (EHAB) | United States | $0.343B | 22.57 |
| LifeMD (LFMD) | United States | $0.297B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.144B | 23.50 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.096B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.034B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |